Key result
Topical application of Epidermal Growth Factor with amniotic membrane significantly reduced tympanic membrane perforation diameter by 21.1% at 2 weeks compared to 0% without EGF (p<0.05).
Why the study?
Does topical Epidermal Growth Factor (EGF) application reduce tympanic membrane perforation diameter in patients with chronic tympanic membrane perforation?
RCT (n=20)
randomized
Does topical Epidermal Growth Factor (EGF) application reduce tympanic membrane perforation diameter in patients with chronic tympanic membrane perforation?
Absolute Event Rate: 21.1% vs 0%
p-value: p=<0.05
Topical application of epidermal growth factor accelerates the closure of chronic tympanic membrane perforations when used with amniotic membrane grafts.
Supports adjunctive topical EGF with amniotic grafts for chronic perforations; confirms accelerated healing in this RCT.
Background and Objective: Some researches have already been conducted about the effect of topical application of Epidermal Growth Factor (EGF) in the use of amniotic graft to changes in tympanic membrane perforation diameter.The aim of this research was to know the effects of topical Epidermal Growth Factor (EGF) application in graft amnion usage on perforation membraneʼs diameter which compared to the control.Materials and Methods: The research method used was experimental with randomized pre-test and post-test control group design.Patients with chronic tympanic membrane perforation without infection were injured at the perforated edge using a sickle knife which was then smeared with a topical epidermal growth factor then perforation closes with the amniotic membrane.There were 20 samples consisting of 10 samples with amnion membrane without topical EGF and 10 samples with amnion membrane plus topical EGF.Results: The results obtained in the EGF group had significantly reduced perforated diameter (p<0.05) by 21.1% during the 2nd week; whereas in the group without EGF has not been reduced at all.This means that there was a faster decrease in perforated diameter in the topical group treated with EGF than in the top group without the topical EGF, since the 2nd week and significantly different in the 5th week.Conclusion: Epidermal growth factor plays a role in shrinking the perforation diameter of the tympanic membrane on the use of amniotic membranes as graft.
No takes yet. Share an insight, caveat, or question.
Djamin et al. (2018) conducted an RCT in chronic tympanic membrane perforation without infection (n=20). Topical Epidermal Growth Factor (EGF) plus amniotic membrane vs. Amniotic membrane without topical EGF was evaluated on Reduction in perforated diameter at 2nd week (p=<0.05). Topical application of Epidermal Growth Factor with amniotic membrane significantly reduced tympanic membrane perforation diameter by 21.1% at 2 weeks compared to 0% without EGF (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: